Arich Enterprise Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 07, 2022 at 02:37 pm
Share
Arich Enterprise Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 281.24 million compared to TWD 248.34 million a year ago. Revenue was TWD 263.96 million compared to TWD 229.06 million a year ago. Net income was TWD 16.86 million compared to TWD 9.03 million a year ago. Basic earnings per share from continuing operations was TWD 0.23 compared to TWD 0.12 a year ago. Diluted earnings per share from continuing operations was TWD 0.23 compared to TWD 0.12 a year ago.
For the nine months, sales was TWD 814.63 million compared to TWD 742.12 million a year ago. Revenue was TWD 759.63 million compared to TWD 701.62 million a year ago. Net income was TWD 49.01 million compared to TWD 30.3 million a year ago. Basic earnings per share from continuing operations was TWD 0.66 compared to TWD 0.41 a year ago. Diluted earnings per share from continuing operations was TWD 0.66 compared to TWD 0.41 a year ago.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
